These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1259789)

  • 21. Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man.
    Williams M; Young JB; Rosa RM; Gunn S; Epstein FH; Landsberg L
    J Clin Invest; 1986 Dec; 78(6):1687-93. PubMed ID: 3097077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of L-aromatic amino acid decarboxylase inhibition on metabolism of dihydroxyphenylalanine by isolated perfused rat liver.
    Tyce GM; Owen CA
    Biochem Pharmacol; 1972 Nov; 21(22):2977-89. PubMed ID: 4649349
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of hydrazine on urea cycle enzymes in vitro and in vivo.
    Roberge A; Gosselin C; Charbonneau R
    Biochem Pharmacol; 1971 Sep; 20(9):2231-8. PubMed ID: 5163140
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
    Jones MK; Ramsay ID; Jenner PG
    Br J Clin Pharmacol; 1978 May; 5(5):425-30. PubMed ID: 656281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of carbidopa and dimethyl sulfoxide on the permeability of the hemato-encephalic barrier for 14C-tyrosine and 14C-DOPA in rats].
    Borisenko SA
    Biull Eksp Biol Med; 1988 Dec; 106(12):686-8. PubMed ID: 3145042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [DOPA-DOPP-transaminases of rat brain in vitro].
    Gey KF
    Helv Physiol Pharmacol Acta; 1967; 25(2):CR187-9. PubMed ID: 5588161
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.
    Fermaglich J
    Med Ann Dist Columbia; 1974 Dec; 43(12):587-91. PubMed ID: 4532167
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects.
    Szabo M; Nakawatase C; Kovathana N; Frohman LA
    Neuroendocrinology; 1977; 24(1):24-34. PubMed ID: 600362
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction of L-alpha-methyl-alpha-hydrazino-3,4 dihydroxyphenylpropionic acid with dopa-decarboxylase from pig kidney.
    Borri-Voltattorni C; Minelli A; Borri P
    FEBS Lett; 1977 Mar; 75(1):277-80. PubMed ID: 852589
    [No Abstract]   [Full Text] [Related]  

  • 30. Action of phenytoin, ethosuximide and of the carbidopa-L-dopa association in semi-chronic cobalt-induced epilepsy in the rat.
    Scuvee-Moreau J; Lepot M; Brotchi J; Gerebtzoff MA; Dresse A
    Arch Int Pharmacodyn Ther; 1977 Nov; 230(1):92-9. PubMed ID: 603313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of benserazide, carbidopa and isoniazid administration on tryptophan-nicotinamide nucleotide metabolism in the rat.
    Bender DA
    Biochem Pharmacol; 1980 Aug; 29(15):2099-104. PubMed ID: 6447505
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.
    Cumming P; Häusser M; Martin WR; Grierson J; Adam MJ; Ruth TJ; McGeer EG
    Biochem Pharmacol; 1988 Jan; 37(2):247-50. PubMed ID: 3124856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
    Bartholini G; Pletscher A
    J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
    [No Abstract]   [Full Text] [Related]  

  • 34. [Enzymatic research at the mitochondrial level in experimental carbon monoxide poisoning. Behavior of the cytochrome oxidases, aldolases and glutamic-oxalacetic and glutamic-pyruvic transaminases in the hepatic and renal mitochondria].
    VILLA T; ANDRI L; BRASCA F
    Folia Med (Napoli); 1961 Jun; 44():486-95. PubMed ID: 13781376
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A; Vacca U; Pirro R; Cerone G
    Clin Ter; 1975 Aug; 74(3):265-70. PubMed ID: 1227747
    [No Abstract]   [Full Text] [Related]  

  • 36. [Coenzyme role of hydrazones of pyridoxal phosphate with respect to dopa decarboxylation].
    GONNARD P; NGUYEN CHI JP
    Bull Soc Chim Biol (Paris); 1959; 41():1455-61. PubMed ID: 13850964
    [No Abstract]   [Full Text] [Related]  

  • 37. L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
    Goshima Y; Nakamura S; Misu Y
    J Pharmacol Exp Ther; 1991 Aug; 258(2):466-71. PubMed ID: 1865350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.
    Jeffrey RF; MacDonald TM; Marwick K; Lee MR
    Br J Clin Pharmacol; 1988 Feb; 25(2):195-201. PubMed ID: 3129006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of L-thyroxine due to transamination by rat kidney mitochondria.
    YAMAMOTO K; ISHIKAWA I; SHIMIZU S
    Jpn J Physiol; 1960 Apr; 10():221-33. PubMed ID: 13846406
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone?
    Ball SG; Lee MR
    Br J Clin Pharmacol; 1977 Apr; 4(2):115-9. PubMed ID: 861126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.